The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 860-869

  Klein, Christian ^a   Wüstefeld, Torsten ^a   Assmus, Ulrike ^a   Roskams, Tania ^b   Rose John, Stefan ^c   Müller, Michael ^d   Manns, Michael P ^a   Ernst, Mattias ^e   Trautwein, Christian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF KIEL   (Germany)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE KC; CONCANAVALIN A; GLYCOPROTEIN GP 130; IMMEDIATE EARLY PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS PROTEIN; SERUM AMYLOID A; SERUM AMYLOID A2; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; HEPATITIS; IMMUNE MEDIATED INJURY; KNOCKOUT MOUSE; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 16844387413     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23640     Document Type: Article

References (50)

1. Mizuhara, H., et al. 1994. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179:1529-1537.
2. Kovalovich, K., et al. 2000. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology. 31:149-159.
3. Klein, C., et al. 2003. ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism. Eur. J. Immunol. 33:2251-2261.
4. Hong, F., et al. 2002. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene. 21:32-43.
5. Kovalovich, K., et al. 2001. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J. Biol. Chem. 276:26605-26613.
6. Camargo, C.A., Jr., Madden, J.F., Gao, W., Selvan, R.S., and Clavien, P.A. 1997. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology. 26:1513-1520.
7. Sun, Z., et al. 2003. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology. 125:202-215.
8. Casini, A., Ricci, O.E., Paoletti, F., and Surrenti, C. 1985. Immune mechanisms for hepatic fibrogenesis. T-lymphocyte-mediated stimulation of fibroblast collagen production in chronic active hepatitis. Liver. 5:134-141.
9. Moebius, U., et al. 1990. T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones. Eur. J. Immunol. 20:889-896.
10. Ramadori, G., Moebius, U., Dienes, H.P., Meuer, S., and Meyerzum Buschenfelde, K.H. 1990. Lymphocytes from hepatic inflammatory infiltrate kill rat hepatocytes in primary culture. Comparison with peripheral blood lymphocytes. Virchows Arch., B, Cell Pathol. 59:263-270.
11. Trautwein, C, et al. 1998. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology. 114:1035-1045.
12. Bonder, CS., Ajuebor, M.N., Zbytnuik, L.D., Kubes, P., and Swain, M.G. 2004. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J. Immunol. 172:45-53.
13. Dienes, H.P., Hutteroth, T., Hess, G., and Meuer, S.C. 1987. Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology. 7:1317-1325.
14. Russell, J.Q., et al. 1998. Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens. J. Exp. Med. 188:1147-1157.
15. Sitia, G., et al. 2002. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 99:13717-13722.
16. Schumann, J., et al. 2000. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am. J. Pathol. 157:1671-1683.
17. Jaeschke, H. 2002. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol. 27:23-27
18. Jaeschke, H., and Farhood, A. 1991. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 260:G355-G362.
19. Ishihara, K., and Hirano, T. 2002. Molecular basis of the cell specificity of cytokine action. Biochim. Biophys. Acta. 1592:281-296.
20. Stahl, N., et al. 1995. Choice of STATs and other substrates specified by modular cyrosine-based motifs in cytokine receptors. Science. 267:1349-1353.
21. Nakajima, K., et al. 1996. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15:3651-3658.
22. Fukada, T., et al. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity. 5:449-460.
23. Ernst, M., and Jenkins, B.J. 2004. Acquiring signaling specificity from the cytokine receptor gp130. Trends Genet. 20:23-32.
24. Rose-John, S. 2001. Coordination of interleukin-6 biology by membrane bound and soluble receptors. Adv. Exp. Med. Biol. 495:145-151.
25. Streetz, K.L, et al. 2003. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology. 125:532-543.
26. Betz, U.A., et al. 1998. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J. Exp. Med. 188:1955-1965.
27. Cao, Q., Batey, R., Pang, G., Russell, A., and Clancy, R. 1998. IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunol. Cell Biol. 76:542-549.
28. Okamoto, T., et al. 1998. Expression of cytokine mRNA in extrahepatic organs in a mouse concanavalin A-hepatitis model. Jpn. J. Pharmacol. 77:219-225.
29. Hong, F., et al. 2002. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110:1503-1513. doi:10.1172/JCI200215841.
30. Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F., and Graeve, L. 1998. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem. J. 334:297-314.
31. Taga, T., and Kishimoto, T. 1997. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797-819.
32. Tebbutt, N.C., et al. 2002. Reciprocal regulation of gastrointestinal homeostasis bySHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8:1089-1097.
33. Stix, B., et al. 2001. Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3. Am. J. Pathol. 159:561-570.
34. Wiekowski, M.T., et al. 2001. Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J. Immunol. 167:7102-7110.
35. Bustos, M., et al. 2003. Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology. 125:192-201.
36. Mahboubi, K., Biedermann, B.C., Carroll, J.M., and Pober, J.S. 2000. IL-11 activates human endothelial cells to resist immune-mediated injury. J. Immunol. 164:3837-3846.
37. Sun, R., Tian, Z., Kulkarni, S., and Gao, B. 2004. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners. J. Immunol. 172:5648-5655.
38. Toyabe, S., et al. 1997. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159:1537-1542.
39. Peters, M., Meyer zum Buschenfelde, K.H., and Rose-John, S. 1996. The function of the soluble IL-6 receptor in vivo. Immunol. Lett. 54:177-184.
40. Peters, M., et al. 1996. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1399-1406.
41. Gantner, F., Leist, M., Lohse, A.W., Germann, P.G., and Tiegs, G. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 21:190-198.
42. Nicoletti, F., et al. 2000. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. Cytokine. 12:315-323.
43. Croker, B.A., et al. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4:540-545.
44. Wielockx, B., et al. 2001. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat. Med. 7:1202-1208.
45. Bozic, C.R., et al. 1995. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154:6048-6057.
46. Lira, S.A., et al. 1994. Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J. Exp. Med. 180:2039-2048.
47. Huo, Y., et al. 2001. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108:1307-1314. doi:10.1172/JCI200112877.
48. Ernst, M., et al. 2001. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J. Exp. Med. 194:189-203.
49. Rakemann, T., et al. 1999. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro. J. Biol. Chem. 274:1257-1266.
50. Gjessing, R., and Seglen, P.O. 1980. Adsorption, simple binding and complex binding of rat hepatocytes to various in vitro substrata. Exp. Cell Res. 129:239-249.